These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Stimulation of cholesterol excretion by the liver X receptor agonist requires ATP-binding cassette transporters G5 and G8. Yu L; York J; von Bergmann K; Lutjohann D; Cohen JC; Hobbs HH J Biol Chem; 2003 May; 278(18):15565-70. PubMed ID: 12601003 [TBL] [Abstract][Full Text] [Related]
7. Increased hepatobiliary and fecal cholesterol excretion upon activation of the liver X receptor is independent of ABCA1. Plōsch T; Kok T; Bloks VW; Smit MJ; Havinga R; Chimini G; Groen AK; Kuipers F J Biol Chem; 2002 Sep; 277(37):33870-7. PubMed ID: 12105210 [TBL] [Abstract][Full Text] [Related]
8. Type I diabetes mellitus decreases in vivo macrophage-to-feces reverse cholesterol transport despite increased biliary sterol secretion in mice. Freark de Boer J; Annema W; Schreurs M; van der Veen JN; van der Giet M; Nijstad N; Kuipers F; Tietge UJF J Lipid Res; 2012 Mar; 53(3):348-357. PubMed ID: 22180634 [TBL] [Abstract][Full Text] [Related]
9. Activation of the liver X receptor stimulates trans-intestinal excretion of plasma cholesterol. van der Veen JN; van Dijk TH; Vrins CL; van Meer H; Havinga R; Bijsterveld K; Tietge UJ; Groen AK; Kuipers F J Biol Chem; 2009 Jul; 284(29):19211-9. PubMed ID: 19416968 [TBL] [Abstract][Full Text] [Related]
10. NPC1L1 and ABCG5/8 induction explain synergistic fecal cholesterol excretion in ob/ob mice co-treated with PPAR-α and LXR agonists. Srivastava RAK; Cefalu AB; Srivastava NS; Averna M Mol Cell Biochem; 2020 Oct; 473(1-2):247-262. PubMed ID: 32661772 [TBL] [Abstract][Full Text] [Related]
11. Ezetimibe inhibits hepatic Niemann-Pick C1-Like 1 to facilitate macrophage reverse cholesterol transport in mice. Xie P; Jia L; Ma Y; Ou J; Miao H; Wang N; Guo F; Yazdanyar A; Jiang XC; Yu L Arterioscler Thromb Vasc Biol; 2013 May; 33(5):920-5. PubMed ID: 23471229 [TBL] [Abstract][Full Text] [Related]
12. Liver X receptor-mediated activation of reverse cholesterol transport from macrophages to feces in vivo requires ABCG5/G8. Calpe-Berdiel L; Rotllan N; Fiévet C; Roig R; Blanco-Vaca F; Escolà-Gil JC J Lipid Res; 2008 Sep; 49(9):1904-11. PubMed ID: 18509196 [TBL] [Abstract][Full Text] [Related]
13. Liver X receptor activation promotes macrophage-to-feces reverse cholesterol transport in a dyslipidemic hamster model. Briand F; Tréguier M; André A; Grillot D; Issandou M; Ouguerram K; Sulpice T J Lipid Res; 2010 Apr; 51(4):763-70. PubMed ID: 19965597 [TBL] [Abstract][Full Text] [Related]
14. Lack of Abcg1 results in decreased plasma HDL cholesterol levels and increased biliary cholesterol secretion in mice fed a high cholesterol diet. Wiersma H; Nijstad N; de Boer JF; Out R; Hogewerf W; Van Berkel TJ; Kuipers F; Tietge UJ Atherosclerosis; 2009 Sep; 206(1):141-7. PubMed ID: 19339012 [TBL] [Abstract][Full Text] [Related]
15. Hepatic ABCG5/G8 overexpression substantially increases biliary cholesterol secretion but does not impact in vivo macrophage-to-feces RCT. Dikkers A; de Boer JF; Groen AK; Tietge UJ Atherosclerosis; 2015 Dec; 243(2):402-6. PubMed ID: 26520893 [TBL] [Abstract][Full Text] [Related]
16. Evidence that the adenosine triphosphate-binding cassette G5/G8-independent pathway plays a determinant role in cholesterol gallstone formation in mice. Wang HH; Li X; Patel SB; Wang DQ Hepatology; 2016 Sep; 64(3):853-64. PubMed ID: 27014967 [TBL] [Abstract][Full Text] [Related]
17. Abcg5/8 independent biliary cholesterol excretion in Atp8b1-deficient mice. Groen A; Kunne C; Jongsma G; van den Oever K; Mok KS; Petruzzelli M; Vrins CL; Bull L; Paulusma CC; Oude Elferink RP Gastroenterology; 2008 Jun; 134(7):2091-100. PubMed ID: 18466903 [TBL] [Abstract][Full Text] [Related]
18. Liver-specific Lxr inhibition represses reverse cholesterol transport in cholesterol-fed mice. Nishida T; Ayaori M; Arakawa J; Suenaga Y; Shiotani K; Uto-Kondo H; Komatsu T; Nakaya K; Endo Y; Sasaki M; Ikewaki K Atherosclerosis; 2024 Oct; 397():117578. PubMed ID: 38797615 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo. Naik SU; Wang X; Da Silva JS; Jaye M; Macphee CH; Reilly MP; Billheimer JT; Rothblat GH; Rader DJ Circulation; 2006 Jan; 113(1):90-7. PubMed ID: 16365197 [TBL] [Abstract][Full Text] [Related]
20. ApoE promotes hepatic selective uptake but not RCT due to increased ABCA1-mediated cholesterol efflux to plasma. Annema W; Dikkers A; Freark de Boer J; Gautier T; Rensen PCN; Rader DJ; Tietge UJF J Lipid Res; 2012 May; 53(5):929-940. PubMed ID: 22383685 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]